ET
LH icon

Equitable Trust’s Labcorp LH Stock Holding History

Equitable Trust’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6M Sell
70,028
-7,079
-9% -$1.86M 0.82% 29
2026
Q1 		$20.6M Buy
77,107
+1,449
+2% +$392K 0.95% 22
2025
Q4 		$19M Sell
75,658
-770
-1% -$205K 0.85% 25
2025
Q3 		$21.9M Sell
76,428
-999
-1% -$268K 1.01% 24
2025
Q2 		$20.3M Buy
77,427
+2,644
+4% +$644K 1.01% 25
2025
Q1 		$17.4M Sell
74,783
-5,382
-7% -$1.31M 0.96% 24
2024
Q4 		$18.4M Sell
80,165
-7,622
-9% -$1.75M 1.03% 22
2024
Q3 		$19.6M Buy
87,787
+3,468
+4% +$762K 1.26% 16
2024
Q2 		$17.2M Sell
84,319
-42,880
-34% -$8.72M 1.18% 17
2024
Q1 		$27.8M Sell
127,199
-4,043
-3% -$891K 1.93% 8
2023
Q4 		$29.8M Buy
131,242
+17,298
+15% +$3.63M 2.24% 9
2023
Q3 		$22.9M Buy
113,944
+14,231
+14% +$3M 1.89% 11
2023
Q2 		$20.7M Buy
99,713
+10,610
+12% +$2.06M 1.58% 17
2023
Q1 		$17.6M Buy
89,103
+23,666
+36% +$4.87M 1.38% 17
2022
Q4 		$13.2M Buy
+65,437
New +$12.8M 1.04% 24

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Equitable Trust's LH Position: Q2 2026 in Review

Equitable Trust reduced its Labcorp (LH) stake by 9.2% in Q2 2026, selling an estimated $1.86M and leaving 70,028 shares worth $19.6M. The position accounts for 0.82% of the portfolio, ranked #29.

Equitable Trust first reported a position in LH in Q4 2022 and has held it in 15 quarters since. The position peaked at $29.8M in Q4 2023. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Equitable Trust held 70,028 shares of Labcorp worth $19.6M as of Q2 2026.
  • Equitable Trust sold 7,079 Labcorp shares in Q2 2026, an estimated $1.86M.
  • Labcorp made up 0.82% of Equitable Trust's portfolio in Q2 2026, its #29 holding.
  • Equitable Trust first reported a position in Labcorp in Q4 2022 and has held it in 15 quarters since.
  • Equitable Trust's Labcorp position peaked at $29.8M in Q4 2023.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.